Viveve Medical, Inc. announced that it has initiated enrollment in its three-arm, three-month feasibility study to compare Viveve’s cryogen-cooled monopolar radiofrequency (CMRF) treatment and a cryogen-only sham to an inert sham treatment for the improvement of stress urinary incontinence (SUI) in women. Approval of the Investigational Testing Application from the Canadian Ministry of Health to conduct the study was reported in mid-December 2019.